← All candidates
One insider buy in the last year — $12.50M in all.
6 filings on record.
ZURAZura Bio Ltd
—
$3.70
+3.35% · Jun 12
One insider buy in the last year — $12.50M in all.
Nothing in the last fortnight.
Price · 1Y · daily● 1 buy◆ 13 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Short % float
Pro
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
10% owner
AI Biotechnology LLC
Bought $12.50M on Feb 26 — 2,000,000 sh @ $6.25, held direct, 31% of their stake.
0 of 1 position beat the S&P
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
Context
Wall St
$18.00 avg target
+386.5% vs today · 6 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
0 of 4 quarters beat
Q2 '26−$0.21 act−$0.02
Q1 '26−$0.22 act−$0.04
Q4 '25−$0.49 act−$0.34
Q3 '25−$0.21 act−$0.03
Coverage
Zura Bio (ZURA) Hits Enrollment Milestones As Losses Widen SharplyInsider Monkey · 6d agoWilliam Blair Starts Zura Bio (ZURA) at OutperformInsider Monkey · 07-14Here's Why We're Not Too Worried About Zura Bio's (NASDAQ:ZURA) Cash Burn SituationSimply Wall St. · 06-03One Zura Bio Insider Raised Their Stake In The Previous YearSimply Wall St. · 04-23
The file stays open
6 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice